Schedule 13G ownership disclosure

CATALYST BIOSCIENCES, INC.

Security class unavailable · CUSIP: 14888D109

Event date: 2018-01-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
340,676
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-004732
Form type
SC 13G
Filer
GYRE THERAPEUTICS, INC.
CIK
CIK 1124105
Filed
Jan 29, 2018
Reporting period
Jan 19, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub